Viewing research peptides. User acknowledges these products are not for human nor veterinary use. Review Legal Waiver →

Tirzepatide is a linear 39-amino acid synthetic peptide modified with a C20 fatty diacid moiety that binds both GIP and GLP-1 receptor domains. Preclinical and in-vitro investigations explore its biased signaling dynamics, receptor internalization kinetics, and endocrine cross-talk in pancreatic and adipocyte cell lines. Prepared under inert conditions to maintain peptide backbone integrity. Verified at ≥99% purity via reverse-phase HPLC. Supplied strictly for laboratory research.

Chemical & Analytical Specifications

Compound Identifier Tirzepatide (Dual GIP/GLP-1 Receptor Agonist)
Sequence / Structure Tyr-{Aib}-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-{Aib}-Leu-Asp-Lys-Ile-Ala-Gln-Lys-{C20-diacid}-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2
Molecular Formula C225H348N48O68
Molecular Weight 4813.45 g/mol
CAS Number 2023788-19-2
Purity Specification ≥99.0% (HPLC & Mass Spectrometry)
Supplied Format Lyophilized powder in borosilicate glass vial
Research Classification Dual incretin receptor pathway probe

Laboratory Handling & Solvent Protocols

To preserve structural integrity and peptide purity, lyophilized materials should be maintained at -20°C in an airtight container protected from ambient moisture and light. Reconstitution should be conducted under sterile conditions using bacteriostatic water (0.9% benzyl alcohol) or sterile laboratory saline. Allow the diluent to run gently down the interior vial wall; avoid vigorous shaking or vortexing to prevent shear-induced degradation. Reconstituted aliquots must be stored at 2°C to 8°C and evaluated within 28 to 30 days.

REGULATORY COMPLIANCE NOTICE All èvelan research products are strictly synthesized and supplied for laboratory research, analytical characterization, and scientific assay evaluation only. These materials are not intended, formulated, or approved for human, clinical, veterinary, or diagnostic application. Distribution is restricted to authorized personnel who affirm adherence to relevant institutional and laboratory safety protocols.

Tirzepatide (Dual GIP/GLP-1 Receptor Agonist)

$293.00

Research Pathways & Profile

Tirzepatide is a linear 39-amino acid synthetic peptide modified with a C20 fatty diacid moiety that binds both GIP and GLP-1 receptor domains. Preclinical and in-vitro investigations explore its biased signaling dynamics, receptor internalization kinetics, and endocrine cross-talk in pancreatic and adipocyte cell lines. Prepared under inert conditions to maintain peptide backbone integrity. Verified at ≥99% purity via reverse-phase HPLC. Supplied strictly for laboratory research.

Format & Concentration: 10mg Lyophilized Vial
≥99% HPLC Analytical Standard
Synthesized in Certified Facility
Direct Express Lab Fulfillment
Analytical Specifications & Sequence

Sequence: Tyr-{Aib}-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-{Aib}-Leu-Asp-Lys-Ile-Ala-Gln-Lys-{C20-diacid}-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2 | Formula: C225H348N48O68 | Molecular Weight: 4813.45 g/mol | CAS Number: 2023788-19-2 | Purity: ≥99.0% (RP-HPLC, ESI-MS) | Sterile Lyophilized Formulation.

Handling, Solvent & Storage Guidelines

Laboratory Assay Standard. Storage: -20°C (lyophilized powder, protected from light) or 2°C to 8°C (short-term reconstituted solution). Reconstitution: Bacteriostatic water (0.9% benzyl alcohol) via sterile interior wall flow without vortexing. Strictly prohibited for human, veterinary, or clinical use.

1All peptide compounds cataloged are intended exclusively for laboratory research, biochemical assays, and analytical characterization. Strictly not for human, veterinary, diagnostic, or therapeutic administration.
2Analytical purity (≥99%) is validated via High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS). Compound integrity is dependent on adherence to cold-chain storage and inert handling protocols.
3The acquiring entity assumes sole responsibility for regulatory compliance, laboratory safety protocols, and safe handling in accordance with federal, state, and local standards. èvelan expressly disclaims liability for off-label or unapproved application.
View Full Legal & Research Disclaimer →